Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease

Medicine and Dentistry

• Chronic Kidney Disease 100%
• Pioglitazone 60%
• Patient 60%
• Cardiovascular Disease 30%
• Myocardial Infarction 30%
• Patient with Diabetes 30%
• Apoplexy 30%
• Cardiovascular System 20%
• All Cause Mortality 20%
• Macrovascular Disease 20%
• Hazard Ratio 10%
• Diabetes 10%
• Kidney Function 10%
• Deterioration 10%
• Cause of Death 10%
• Post-Hoc Analysis 10%
• Leg Amputation 10%
• Leg Revascularization 10%
• Therapeutic Procedure 10%
• Association 10%
• Ankle 10%
• Clinical Trial 10%
• Death 10%
• Placebo 10%
• Acute Coronary Syndrome 10%